Evidence map›Paper›PMID 18978041›Full record

ArticleMolecular pharmacology2009

Preferential physical and functional interaction of pregnane X receptor with the SMRTalpha isoform.

Chia-Wei Li, Gia Khanh Dinh, J Don Chen

Open access · greenAbstract read
In one paragraph

Article in Molecular pharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. PXR: a center of transcriptional regulation in cancer.Acta pharmaceutica Sinica. B · 2020
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Chia-Wei LiDepartment of Pharmacology,University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854-5635, USA.
Gia Khanh Dinh
J Don Chen
Rutgers, The State University of New Jersey · US

Funding

MOLECULAR ACTIONS OF NUCLEAR RECEPTOR COREPRESSOR SMRTR01DK052542 · NIDDK · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI CHEN, J. DON · 1998 to 2002
$637k
NIDDK NIH HHS DK52542NIDDK NIH HHS R01 DK052542
6 · The paper itself

Abstract

The silencing mediator for retinoid and thyroid hormone receptors (SMRT) serves as a platform for transcriptional repression elicited by several steroid/nuclear receptors and transcription factors. SMRT exists in two major splicing isoforms, alpha and tau, with SMRTalpha containing only an extra 46-amino acid sequence inserted immediately downstream from the C-terminal corepressor motif. Little is known about potential functional differences between these two isoforms. Here we show that the pregnane X receptor (PXR) interacts more strongly with SMRTalpha than with SMRTtau both in vitro and in vivo. It is interesting that the PXR-SMRTalpha interaction is also resistant to PXR ligand-induced dissociation, in contrast to the PXR-SMRTtau interaction. SMRTalpha consistently inhibits PXR activity more efficiently than does SMRTtau in transfection assays, although they possess comparable intrinsic repression activity and association with histone deacetylase. We further show that the mechanism for the enhanced PXR-SMRTalpha interaction involves both the 46-amino acid insert and the C-terminal corepressor motif. In particular, the first five amino acids of the SMRTalpha insert are essential and sufficient for the enhanced binding of SMRTalpha to PXR. Furthermore, we demonstrate that Tyr2354 and Asp2355 residues of the SMRTalpha insert are most critical for the enhanced interaction. In addition, expression data show that SMRTalpha is more abundantly expressed in most human tissues and cancer cell lines, and together these data suggest that SMRTalpha may play a more important role than SMRTtau in the negative regulation of PXR.

Indexed as

AnimalsDNA-Binding ProteinsGene SilencingHumansMiceNuclear Receptor Co-Repressor 2Pregnane X ReceptorProtein IsoformsRabbitsReceptors, SteroidRepressor ProteinsTranscription FactorsTumor Cells, CulturedDNA-Binding ProteinsNCOR2 protein, humanNcor2 protein, mouseNuclear Receptor Co-Repressor 2Pregnane X ReceptorProtein IsoformsReceptors, SteroidRepressor ProteinsTranscription Factors

Identifiers

PMID18978041
PMCPMC2629818
OpenAlexW2010120007

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.